Tristel plc
("Tristel" or the "Company")
Confirmation of Interim Results
Analyst and Investor briefing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, confirms it will announce its interim results for the six months ended 31 December 2021 on Monday 21 February 2022.
Analyst briefing
A briefing open to analysts will take place remotely via video conference call on Monday 21 February 2022 at 9.30am. To register and for more details of this call please contact Walbrook PR on tristel@walbrookpr.com
Investor presentation
Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results at an in-person investor presentation on Monday 21 February 2022 at No.1 Cornhill, London, EC3V 3ND from 4.15pm for a 4.30pm start and will be followed by refreshments.
For those that are unable to attend, a live webcast of the investor briefing will be broadcast.
If you would like to register to attend in-person, or require the link for the live webcast, please contact Walbrook PR on 020 7933 8787 or email tristel@walbrookpr.com , ensuring you detail in your email if you will attend in-person or online.
The results presentation will be made available on the Company's website on the day of results - www.tristelgroup.com
For further information please contact:
Tristel plc |
Tel: 01638 721 500 |
|
Paul Swinney, Chief Executive Officer |
|
|
Liz Dixon, Finance Director |
|
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Applegarth |
Mob: 07584 391 303 |
|
|
|
|
finnCap |
Tel: 020 7220 0500 |
|
Geoff Nash/ Charles Beeson (Corporate Finance) |
|
|
Alice Lane (ECM) |
|
|